Results 1 to 10 of about 31,000 (231)

The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study. [PDF]

open access: yesFront Pharmacol
Markovic U   +16 more
europepmc   +1 more source

Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up. [PDF]

open access: yesRes Pract Thromb Haemost
Schimmer R   +6 more
europepmc   +1 more source

Epidemiology, therapy, and outcome of immune-mediated thrombotic thrombocytopenic purpura at population level in Germany. [PDF]

open access: yesRes Pract Thromb Haemost
Scharenberg AY   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy